2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Barrett Esophagus
3
Stomach Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Pulmonary Nodules
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Adenocarcinoma of Lung
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Spinal Fractures
1
Solitary Pulmonary Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Phyllodes Tumor
1
Osteoporosis
1
Nevus
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lung Diseases
1
Interventions
Escitalopram
3
Psilocybin
2
Interpersonal Psychotherapy
2
Infliximab
2
Antidepressive Agents
2
abacavir
1
Vortioxetine
1
Venlafaxine Hydrochloride
1
Transcranial Magnetic Stimulation
1
Sugars
1
Saline Solution
1
Mirtazapine
1
Magnetic Resonance Spectroscopy
1
Ketamine
1
Fatty Acids, Omega-3
1
Diagnostic Imaging
1
Desvenlafaxine Succinate
1
Cognitive Behavioral Therapy
1
Citalopram
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depressive Disorder, Major
×
Diagnostic Imaging
×
Clear all
NCT01718730
2019-10-22
Cortical Excitability and Inhibition in MDD
Mayo Clinic
Completed
23 enrolled